PARK7 and Parkinson disease: Thus, in the present study we address this challenge by investigating transcriptional and morphological changes of microglia in a prodromal model of PD, the PARK7/DJ-1 KO mouse, at 3–4 months, an age corresponding to adulthood in humans [18], where motor symptoms are not manifested yet [55].